Steroids with or without blood thinners for Behçet's vein clots
Part of Eyes & vision, Genetic & congenital, Heart & circulation, Mouth & dental, Skin clinical trials.
This trial tests whether adding a blood thinner (anticoagulant) to steroid therapy is more effective than steroids alone for treating deep vein thrombosis (a blood clot in a large vein) in people with Behçet's syndrome. It aims to find the best way to prevent future clots and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have Behçet's syndrome according to international criteria.
- You have a first or repeat deep vein blood clot (DVT) confirmed by imaging (ultrasound, CT, or MRI).
- You agree to use effective birth control if you could become pregnant.
- You are not already on blood thinners for another condition, and you have no active bleeding or high bleeding risk.
- You have not been on high-dose steroids for more than 6 weeks or on blood thinners for more than 4 weeks recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a blood thinner (rivaroxaban) to standard immune therapy is better than immune therapy alone for treating blood clots in the legs caused by Behçet's disease. It may help prevent clots from getting worse or recurring.
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
This study tests a drug called adalimumab, which helps calm the immune system, when added to the steroid medicine you may already be taking. It aims to see if this combination is safe and works better for people with Behçet's disease that affects the back of the eye and has recently flared up.
This study looks at how the thickness of the femoral vein wall and certain markers of inflammation relate to Behcet disease. It may help doctors better understand and monitor the condition.
This trial tests a new medicine, HSK44459, to see if it can reduce mouth ulcers in people with Behçet's disease. If you have frequent mouth sores from Behçet's, this treatment might help.
This trial tests a combination of blood thinners (anticoagulation) and a drug called tocilizumab, which targets inflammation, to treat acute cerebral venous thrombosis (a blood clot in a vein in the brain). It aims to see if this combined treatment improves recovery and reduces complications compared to blood thinners alone.
Hear when a new Behcet Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.